Common Contracts
4 similar null contracts by Vanda Pharmaceuticals Inc., Delta Petroleum Corp/Co, Volcano CORP
Volcano Corporation 7,000,000 Shares of Common Stock Underwriting AgreementVolcano CORP • October 18th, 2007 • Electromedical & electrotherapeutic apparatus • New York
Volcano Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 7,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,050,000 shares of common stock, par value $0.001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, have or will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights were issued or are to be issued, as applicable, pursuant to a Righ
DELTA PETROLEUM CORPORATION 6,200,000 Shares of Common Stock, par value $0.01 Underwriting AgreementDelta Petroleum Corp/Co • April 25th, 2007 • Crude petroleum & natural gas • New York
Delta Petroleum Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,200,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 930,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
VANDA PHARMACEUTICALS INC. 3,500,000 Shares of Common Stock Underwriting AgreementVanda Pharmaceuticals Inc. • January 17th, 2007 • Pharmaceutical preparations • New York
Vanda Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
VANDA PHARMACEUTICALS INC. 3,500,000 Shares of Common Stock Underwriting AgreementVanda Pharmaceuticals Inc. • January 9th, 2007 • Pharmaceutical preparations • New York
Vanda Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
